TY - JOUR
T1 - Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa—An Analysis of Systematic Review Data
AU - DESTINE NIHR Global Health Research Group
AU - Kassa, Getahun Molla
AU - Lim, Aaron G.
AU - Tamiru, Melaku Tileku
AU - Alamneh, Tesfa Sewunet
AU - Vickerman, Peter
AU - Dagne, Emebet
AU - Mulu, Andargachew
AU - Baissa, Obsie
AU - Paltiel, Ora
AU - Dillon, John F.
AU - Yesuf, Elias Ali
AU - Hickman, Matthew
AU - Walker, Josephine G.
AU - French, Clare E.
AU - Amogne, Wondwossen
AU - Wolday, Dawit
AU - Adane, Aynishet
AU - Abdella, Saro
AU - Abay, Zenahbezu
AU - Hailu, Workagegnehu
AU - Awoke, Tadesse
AU - Weldemariam, Atsbeha Gebreegziabxier
AU - Cabral, Christie
AU - Speakman, Elizabeth
AU - Radley, Andrew
AU - Malaguti, Amy
AU - Inglis, Sarah
AU - Yohannes, Meseret
AU - Taddele, Bruktait
AU - Abraha, Hagos
AU - Erkie, Mengistu
N1 - Publisher Copyright:
© 2025 The Author(s). Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
PY - 2025/10
Y1 - 2025/10
N2 - Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.
AB - Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21–64 (OR = 1.77, 95% CI 1.17–2.68) and 65+ groups (OR = 11.75, 95% CI 5.51–25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35–2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45–2.51) or divorced (OR = 3.20, 95% CI 1.91–5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17–1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61–4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10–2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33–2.45), hospitalisation (OR = 1.55, 95% CI 1.22–1.96), medical operation (OR = 1.28, 95% CI 1.01–1.62), scarification (OR = 1.29, 95% CI 1.01–1.64) and injection drug use (OR = 7.04, 95% CI 1.16–42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.
KW - general population
KW - hepatitis C
KW - meta-analysis
KW - risk factors
KW - sub-Saharan Africa
UR - https://www.scopus.com/pages/publications/105015016967
U2 - 10.1111/jvh.70065
DO - 10.1111/jvh.70065
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 40888503
AN - SCOPUS:105015016967
SN - 1352-0504
VL - 32
JO - Journal of Viral Hepatitis
JF - Journal of Viral Hepatitis
IS - 10
M1 - e70065
ER -